IDEAYA Biosciences Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, IDEAYA Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $52.79. The average 1-year stock price forecast is 69.04% higher than the current stock price, while the lowest is $36 (+15.27%) and the highest is $66 (+111.34%).

Price Target: $52.79 (+69.04%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$36	$52.79	$51.5	$66
Change	+15.27%	+69.04%	+64.91%	+111.34%

Analyst Ratings

The average analyst rating for IDEAYA Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	14	13	13	13	13	11
Buy	3	3	3	3	3	3
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	19	18	18	18	18	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Graig Suvannavejh Mizuho Securities	Mizuho Securities	Buy Maintains $30 → $50	Buy	Maintains	$30 → $50	+60.10%	Jun 16, 2026
Charles Zhu LifeSci Capital	LifeSci Capital	Buy Maintains $65 → $62	Buy	Maintains	$65 → $62	+98.53%	Jun 15, 2026
Robert Driscoll Wedbush	Wedbush	Buy Reiterates $58	Buy	Reiterates	$58	+85.72%	Jun 12, 2026
Michael Yee UBS	UBS	Buy Reiterates $50	Buy	Reiterates	$50	+60.10%	Jun 9, 2026
Corinne Johnson Goldman Sachs	Goldman Sachs	Hold Maintains $35 → $36	Hold	Maintains	$35 → $36	+15.27%	Jun 4, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

33.99M

from 218.71M

-84.46%

from 218.71M

Revenue Next Year

116.80M

from 33.99M

243.65%

from 33.99M

EPS This Year

-4.31

from -1.28

EPS Next Year

-3.66

from -4.31

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	27.94M	50.93M	23.39M	7.00M	218.71M	33.99M
Revenue Growth	43.01%	82.28%	-54.09%	-70.07%	3,024.43%	-84.46%
Gross Profit	-30.22M	-38.61M	-106.12M	-287.67M	-95.99M	33.26M
Gross Margin	-108.15%	-75.80%	-453.81%	-4,109.61%	-43.89%	97.85%
Operating Income	-50.27M	-62.50M	-134.43M	-326.98M	-159.31M	-423.12M
Net Income	-49.76M	-58.66M	-112.96M	-274.48M	-113.70M	-393.10M
EPS	-	-	-	-	-1.28	-4.31
Free Cash Flow	-15.64M	-42.37M	-70.28M	-155.09M	-52.47M	-346.61M
No. Analysts	-	-	-	-	-	16

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	85.5M
Avg	34.0M
Low	n/a

Revenue Growth

Revenue Growth	2026	2027	2028
High	-60.9%
Avg	-84.5%
Low	-100.0%

EPS Forecast

EPS	2026	2027	2028
High	-3.63
Avg	-4.31
Low	-5.00

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-